2025
Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus
Xu H, Aparicio C, Wats A, Araujo B, Pitzer V, Warren J, Shapiro E, Niccolai L, Weinberger D, Oliveira C. Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus. JAMA Network Open 2025, 8: e250380. PMID: 40063022, PMCID: PMC11894488, DOI: 10.1001/jamanetworkopen.2025.0380.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, Monoclonal, HumanizedAntiviral AgentsCase-Control StudiesFemaleHumansInfantMaleRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanTreatment OutcomeConceptsRSV-positive casesCase-control studyRSV infectionLRTI-associated hospitalizationsWeeks postimmunizationLong-acting monoclonal antibodiesTest-negative case-control studyClinical settingRespiratory syncytial virusMultivariate logistic regressionYale New Haven Health SystemRSV diseaseEmergency department dataState immunization registryRSV seasonSyncytial virusNirsevimabPolymerase chain reactionClinical trialsLRTIInfantsPotential confoundersMonoclonal antibodiesBroader outcomesDisease severity
1995
Office pediatrics
McCarthy P, Bachman D, Shapiro E, Baron M. Office pediatrics. Current Opinion In Pediatrics 1995, 7: 107-125. PMID: 7728195, DOI: 10.1097/00008480-199502000-00020.Commentaries, Editorials and LettersMeSH KeywordsBacterial InfectionsChildChild, PreschoolDiarrhea, InfantileFever of Unknown OriginGastroenteritisHemolytic-Uremic SyndromeHumansInfantRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsTobacco Smoke PollutionConceptsCommunity-acquired lower respiratory infectionsLower respiratory tract infectionsInfectious diseasesDiarrhea of infancyLower respiratory infectionsRespiratory tract infectionsPediatric office practiceRespiratory syncytial virusHemolytic uremic syndromeEvaluation of childrenDay care centersProlonged feverTract infectionsAcute feverRespiratory infectionsSyncytial virusClinical examinationCare centerEnterohemorrhagic Escherichia coliStreptococcus pneumoniaeUnknown originOffice settingOffice practiceInfectionAntimicrobial drugs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply